SCHEMBL5951340

SCHEMBL5951340

Oc1ccc(Br)c(N2CCCCC2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
KMT2A Q03164 5/20 0.47
MAPT P10636 4/20 0.47
MEN1 O00255 4/20 0.47
L3MBTL1 Q9Y468 4/20 0.40
TDP1 Q9NUW8 3/20 0.40
HPGD P15428 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
GAA P10253 4/20 0.38
MAPK1 P28482 3/20 0.38
HTT P42858 3/20 0.38
S100B P04271 2/20 0.38
POLB P06746 2/20 0.38
LMNA P02545 1/20 0.38
PKM P14618 1/20 0.38
ALOX15 P16050 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4499783 0.85 ALDH1A1 (0.60) ALDH1A1KMT2AMAPTMEN1L3MBTL1
SCHEMBL3926124 0.80 KMT2A (0.42) ALDH1A1KMT2AMAPTMEN1L3MBTL1
SCHEMBL17659019 0.80 KMT2A (0.42) ALDH1A1KMT2AMAPTMEN1L3MBTL1
SCHEMBL17659703 0.78 MEN1 (0.40) ALDH1A1KMT2AMAPTMEN1L3MBTL1
SCHEMBL9831848 0.78 HTR1A (0.47) ALDH1A1KMT2AMAPTMEN1L3MBTL1
SCHEMBL20424608 0.77 MAPT (0.45) ALDH1A1KMT2AMAPTMEN1L3MBTL1
SCHEMBL11441903 0.76 ALDH1A1 (0.46) ALDH1A1KMT2AMAPTMEN1L3MBTL1
SCHEMBL27810301 0.75 ALDH1A1 (0.46) ALDH1A1KMT2AMAPTMEN1GAA
SCHEMBL20424766 0.74 MAPT (0.43) ALDH1A1KMT2AMAPTMEN1L3MBTL1
SCHEMBL21598636 0.74 ALDH1A1 (0.53) ALDH1A1KMT2AMAPTMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060074102-A1 Kinase inhibitors as therapeutic agents ABBOTT LABORATORIES 2006-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060074102-A1 Kinase inhibitors as therapeutic agents ABL1, MAP3K19, MAP3K20 ALDH1A1 2415/4885KMT2A 891/4885MAPT 2339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.